<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION AND OBJECTIVE: Pyramidal gait impairment (GI) is a classical trait of cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>To developed a method to quantify prospectively and transversely GI and disequilibrium, to be applied in the screening of pyramidal and non-pyramidal syndromes associated to different ethiological subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>; using an Index of Gait and Equilibrium (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IGE</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: In constructing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IGE</z:e>, we used 14 equally weighted semiological variables: 6 measure balance, 6 gait, 1 sensitive abnormalities and 1 <z:hpo ids='HP_0002527'>falls</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Two neurologists separately examined each subject in the same day and repeating the evaluation after a week </plain></SENT>
<SENT sid="4" pm="."><plain>Data analyses included Kruskal Wallis, chi 2, Spearman correlations and Principal Components </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IGE</z:e> was used in 90 subjects, 43 males, with a mean age of 70.6 years </plain></SENT>
<SENT sid="6" pm="."><plain>3 groups of people were formed: 1 </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (A, 21 with silent vascular lesions diagnosed by imaging; B, 17 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>; C, 21 with <z:hpo ids='HP_0001297'>stroke</z:hpo>); 2 </plain></SENT>
<SENT sid="8" pm="."><plain>13 subjects with cautious gait, not associated to any disease; and 3 </plain></SENT>
<SENT sid="9" pm="."><plain>18 <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects (age 60-80 years) </plain></SENT>
<SENT sid="10" pm="."><plain>GI in the non-pyramidal syndrome were significantly related with small vessels disease (chi 2 = 16.37, dof = 1, p &lt; 0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: GI in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, pyramidal and non-pyramidal syndromes were equally frequent </plain></SENT>
<SENT sid="12" pm="."><plain>Increased values of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IGE</z:e> caused by cautious gait in youngest non-<z:hpo ids='HP_0001297'>stroke</z:hpo> patients suggested high probability of silent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and significant association with small vessels disease </plain></SENT>
<SENT sid="13" pm="."><plain>This preliminary assessment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IGE</z:e> showed a reproducible and reliable tool for objectification and quantification of gait disorders </plain></SENT>
</text></document>